Superficial skin mycoses are the most common human’s fungal diseases. Their therapy by systemic and local antifungal drugs is effective in most cases. In recent times, the number of cases of ineffective application of antifungal drugs in regimen recommended by clinical guidelines and medicines’ instructions increased. Prescription of therapy schemes involving simultaneous use of several antifungal drugs allows overcoming low effectiveness of antifungal monotherapy. The number of clinical cases of superficial skin mycoses equal 2 was described: malassezia folliculitis (causative agent — Malassezia sympodialis) and disseminated microsporidiosis (causative agent — Microsporum canis), that at first were poorly responded to antifungal therapy, but eventually were completely cured. Malassezia folliculitis in 18-years-old patient, who took 60 mg/day prednisolone calculated as 1 mg/kg/day and 100 mg/day azathioprine due to pyoderma gangrenosum, was cured by combination of solution with 2% sertaconazole and shampoo with 2% ketoconazole and 1% zinc pyrithione. Moreover, after recovery, further use of shampoo with 2% ketoconazole and 1% zinc pyrithione in a preventive treatment regimen, namely 1—2 times per week, while remaining immunosuppressive state associated with the treatment of pyoderma gangrenosum allowed to predict Malassezia folliculitis recurrence. The combination of griseofulvin application, ingested at a dose of 750 mg/day calculated as 22 mg/kg/day, and local therapy by solution with sertaconazole and shampoo with ketoconazole and zinc pyrithione, was effective in disseminated microsporidiosis of smooth skin with damage of lanugo. Combined therapy with the use of medical antifungal two-component shampoo allowed to increase the treatment effectiveness, accelerate patients’ recovery, prevent the distribution of mycotic infection during washing, and the use of antifungal shampoo in a preventive regimen, namely 1—2 times per week, when long-term immunosuppression — to prevent the recurrence of malassezia-folliculitis.
22 September 2025 in Russian Journal of Skin and Venereal Diseases
Vitamin A belongs to the group of essential fat-soluble vitamins that are not synthesized in the human body and are supplied with food. The primary function of vitamin A metabolites is to regulate cell growth and differentiation during ontogenesis and in the postnatal period. The widespread use of retinoids in dermatology is attributed to their ability to regulate the growth activity and differentiation of keratinocytes and epithelial cells of the sweat and sebaceous glands. To date, pharmaceutical companies continue to work on improving retinoid molecules to enhance their clinical efficacy and reduce the risk of adverse events. At the same time, the clinical era of retinoids is still at an early stage of development, with research in vitamin A biochemistry significantly outpacing the therapeutic applications of its derivatives. This article focuses on the analysis of the structure, functioning, and biological significance of retinoic receptors in cellular signaling. It examines receptor mechanisms, including classification, mechanisms of interaction with ligand molecules, and factors influencing their activity. The main receptor groups, their molecular characteristics, and intracellular signaling mechanisms triggered by synthetic vitamin A derivatives are described in detail. Special attention is given to receptor activation and desensitization processes, which play a pivotal role in regulating physiological processes. The molecular mechanisms underlying receptor activity, including conformational changes, phosphorylation, and interactions with intracellular signaling proteins, are discussed.
1 January 2022 in Russian Journal of Clinical Dermatology and Venereology
Нейрофиброматоз — нейрокутанный синдром (синдром с неврологическими и кожными проявлениями), относится к гетерогенной группе наследственных расстройств механизма подавления опухолевого роста, характеризующихся множественными доброкачественными и злокачественными опухолями кожи и нервной системы. Данная патология имеет разнообразные внекожные проявления: сердечно-сосудистые, желудочно-кишечные, офтальмологические, ортопедические и др., каждое из которых не только существенно снижает качество жизни, но и может влиять на прогноз течения заболевания. Выделяют нейрофиброматоз 1-го типа (ранее известный как болезнь фон Реклингаузена), нейрофиброматоз 2-го типа и шванноматоз, который некоторое время назад считался разновидностью нейрофиброматоза 2-го типа, однако сейчас рассматривается как самостоятельный тип заболевания. Все типы нейрофиброматоза являются генетически детерминированными, аутосомно-доминантными нарушениями, но каждый вариант отличается четким спектром опухолей, встречающихся при каждом конкретном типе, а также набором генов, мутации в которых обусловливают конкретные клинические проявления. В связи с редкой встречаемостью данной патологии постановка диагноза часто вызывает затруднение у практикующих специалистов, особенно в детском возрасте. Представляем разбор клинического случая, демонстрирующий кожные, офтальмологические и ортопедические паттерны нейрофиброматоза 1-го типа, а также демонстрируем отличительные особенности затруднительного диагностического поиска. Необходим мультидисциплинарный подход при данной патологии.
Retinoid dermatitis is a predictable, dose-dependent irritant inflammatory skin reaction that occurs predominantly during the early phase of retinoid therapy and may significantly reduce patient adherence. The increasing frequency of retinoid use and the expansion of indications in both dermatology and cosmetic practice underscore the need for unified approaches to the prevention, diagnosis, and management of retinoid-induced dermatitis. This review systematizes current data on the pathogenesis of retinoid dermatitis, with particular emphasis on RAR/RXRmediated transcriptional reprogramming, epidermal barrier dysfunction accompanied by increased transepidermal water loss (TEWL), inflammatory chemokine activation, and neurosensory sensitization involving transient receptor potential (TRP) channels. The phenomenon of retinization is discussed separately as a physiological adaptive phase of the cutaneous response to retinoid exposure. A clinical and practice-oriented concept is proposed linking the chemical structure of retinoids, receptor selectivity, and tolerability profiles. Risk factors for retinoid dermatitis, approaches to differential diagnosis with allergic contact dermatitis and rosacea, as well as prevention and severity-stratified management algorithms are presented, with a focus on maintaining therapeutic efficacy while minimizing adverse effects.
7 March 2023 in Russian Journal of Clinical Dermatology and Venereology
Perioral dermatitis (PD), often referred to in the literature as steroid dermatitis because of the strong association between its occurrence and the use of topical glucocorticosteroids on the face, is a clinically characteristic and recognizable pattern of skin reaction manifested by erythema, papulopustular rash, and tight, dry skin. The disease is prone to chronicity and usually affects the perioral area (with a characteristic halo of intact skin on the contour of the lips) and, in rare cases, the perinasal and periocular areas. According to recent data, about 6% of women and 0.3% of men visiting dermatologists are diagnosed with perioral dermatitis; therefore, this disease is a very urgent problem in outpatient dermatology. However, this common inflammatory facial dermatosis is not well understood for etiopathogenesis and therapy approaches and requires more extensive and long-term research. Based on the analysis of domestic and foreign studies, this article presents the latest data on the etiology, pathogenesis, and treatment of perioral dermatitis, as well as a clinical case of the effective treatment of severe steroid dermatitis with topical ivermectin 1% cream.
22 April 2024 in Russian Journal of Clinical Dermatology and Venereology
Bowen’s disease (BD) is a superficial variant of squamous cell carcinoma of the skin in situ, arising from atypically altered epidermal keratinocytes found only in the thickness of the epidermis during histological examination. Most often, it looks like a slow-growing pink scaly plaque or spot that occurs mainly on the skin of the trunk and proximal extremities, often exposed to ultraviolet radiation. However, in some rarer cases, melanocyte cells producing the pigment melanin can be activated during this process, and the disease, like actinic keratosis, acquires a pigmented form. The clinical features of pigmented BD are not well described. Diagnostics can be rather challenging, as the disease often shares clinical and dermatoscopic features with other pigmented lesions. The authors of the article analyzed the literature on this topic. It provides the latest data on the etiology and pathogenesis of the disease, describes the features of the clinical and dermatoscopic pattern, and presents 2 clinical cases of the pigmented form of BD, subsequently confirmed by histological examination.